http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-763197-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2603-26
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D317-72
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D317-72
filingDate 1952-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1956-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-763197-A
titleOfInvention Substituted phenanthrene compounds and their preparation
abstract The invention comprises 4b-methyl-1,2,3,4,4a, 4b,5,6,7,9,10,10a - dodecahydrophenanthrene-4-ol-1,7-dione, and the 4-acylates thereof, of the formula <FORM:0763197/IV(b)/1> wherein R1 represents a hydroxy or acyloxy group, and the preparation of a 1-keto-4-hydroxy-polyhydrophenanthrene compound by oxidizing a 1,4-dihydroxy-polyhydrophenanthrene compound with N-bromoacetamide, e.g. the above 4-ol-1,7-dione may be prepared from the corresponding 1,4-diol-7-one by this method preferably in the presence of an organic base such as pyridine. The above 4-ol-1,7-dione can also be prepared by either of the following processes which are claimed:-by hydrolysing the corresponding 4-acylate with alkali; and by subjecting to acid hydrolysis a 4b-methyl-1,2,3,4,4a,4b,5,6,7,8,10,10a - dodecahydrophenanthrene - 4 - ol - 1 - one having in the 7-position a bivalent substituent or two univalent substituents convertible to keto by acid hydrolysis or a 4b - methyl - 1,2,3,4,4a,4b,5,6,10,10a - decahydrophenanthrene - 4 - ol - 1 - one having in the 7-position a univalent group convertible to keto by acid hydrolysis. This process may be modified in that the reactant is prepared by a process described in Specification 763,210. Examples of bivalent substituents are cyclic ketal groups such as the ethylenedioxy, ethylene dithioketal and ethylene henithioketal groups, examples of two univalent groups are the non-cyclic ketals such as dimethyl ketal, and examples of a univalent group are enol ether groups such as the ethyl enol ether group in which case the reactant is a 1,2,3,4,4a, 4b,5,6,10,10a - decahydrophenanthrene compound. Suitable reagents for the acid hydrolysis are hydrochloric and sulphuric acids and substances which give rise to acids such as p - toluene - sulphonyl chloride. The 4 - acylates of the above 4-ol-1,7-dione may be prepared by either of the following processes which are claimed:-by acylating the 4-ol-1,7-dione; and by oxidizing a 4b-methyl-1,2,3,4,4a,4b,5,6, 7,9,10,10a - dodecahydrophenanthrene - 1,4 - diol-7-one-4-acylate (which may be obtained by hydrolysing the corresponding 1,4,7-triacylate with methanolic potassium carbonate) with chromium trioxide. The 1,4,7-triacylate for use in the above process may be prepared by a method claimed in Specification 763,209 in which case the resulting 4-acylate derivative of the above 4 - ol - 1,7 - dione may be stereoisomerized by treatment with a mild base such as sodium bicarbonate, pyridine, and alkaline alumina. The preferred acylate, reactants and product in all the processes referred to above are the acetates. A number of detailed examples are given. Specifications 736,307, 763,198, and 763,208 also are referred to.
priorityDate 1951-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456373471
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154122769
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136353
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412584819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414927286
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154345559
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559542
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6325
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413305291
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11430
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4353
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558805
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414886711
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1118
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20186
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154125919
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7397
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154338447
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393705
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID516892
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1049
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451818717
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419594527
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431994710
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432421723
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537701
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432002427
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432434366
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547992
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14915
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453034310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9989226
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448020525

Total number of triples: 46.